Search Results

Lanzhou Taiji Completes Key Commissioning of First Domestic Multi-Ion Therapy Device HiTS400

The first domestically produced multi-ion therapy device HiTS400, independently developed by Lanzhou Taiji and installed at Shandong Cancer Hospital, recently completed phased joint commissioning. After one week of operational testing, all beam parameters of the device met or exceeded contractual requirements, laying the foundation for subsequent clinical registration work. According to reports, HiTS400 is a medical ion accelerator independently developed by Lanzhou Taiji with full intellectual property rights. It can stably deliver four ion species: C^6+, H^+, He^2+, and O^8+, and is equipped with multi-angle fixed treatment nozzles and a lightweight superconducting heavy-ion rotating gantry, integrating modulated scanning technology to advance the development and application of multi-ion combined therapy devices. On August 14, 2026, the device obtained an amendment to its Radiation Safety License from the Ministry of Ecology and Environment, granting qualification for commissioning and operation. In the early morning of August 20, the equipment achieved stable acceleration and precise extraction of carbon ion beams. Measured data show that the particle number after synchrotron acceleration reached 3.26E9 ppp, the terminal particle number reached 3.02E9 ppp, the extraction efficiency was 92%, and beam stability was no less than 95%.

2026-08-26

UK's InHealth Deploys Europe's First Mobile Biograph Trinion PET/CT System

InHealth, a UK independent diagnostic service provider, has recently completed the first patient scan using Europe's first mobile Biograph Trinion PET/CT system. The system, supplied by Siemens Healthineers, is now in clinical use at Wrexham Maelor Hospital in northeast Wales to support cancer-related molecular imaging examinations. PET/CT is an important imaging technology in oncology diagnosis and treatment, applicable to the diagnosis, staging, treatment planning, and therapy response monitoring of various cancer types. Deploying the Biograph Trinion PET/CT system on a mobile platform means that advanced molecular imaging services can be delivered into clinical settings with greater flexibility, helping to improve patient access to...

2026-08-26

Korea's Gil Medical Center Expands Application of Markerless Surface-Guided Radiation Therapy

Gachon University Gil Medical Center in South Korea announced on August 26 that it is expanding the clinical application of markerless surface-guided radiation therapy (SGRT) to enhance the precision and comfort of radiation therapy for cancer patients. According to the hospital, the proportion of markerless SGRT in its radiation therapy procedures has increased from 28% in the first half of 2025 to 37% in the first half of 2026. This change indicates that this treatment-assistive technology, which reduces the burden of skin marking on patients, is gaining broader clinical adoption. Markerless SGRT is an advanced technique used for patient positioning and monitoring during radiation therapy. Unlike conventional methods, patients do not need to retain target line markings on their skin; the treatment system can assist in confirming patient positioning through surface guidance, enabling radiation to be delivered more accurately to the target area.

2026-08-26

South Korean lawmaker calls for heavy ion therapy center in Daejeon to ease regional cancer treatment disparities

South Korean lawmaker Park Yong-gap recently called on the government to support the construction of a heavy ion therapy center in the central region of Daejeon, aiming to improve access to advanced radiation therapy for cancer patients outside the capital area and promote a balanced distribution of regional medical resources. Park stated that heavy ion therapy centers are often referred to as "dream cancer treatment centers." Compared with conventional radiation therapy, heavy ion therapy and proton therapy can target cancer cells more precisely while minimizing impact on surrounding normal tissues, making them advanced particle therapy technologies drawing attention in the current cancer treatment field. According to him, the relevant treatment centers currently in operation in South Korea are mainly concentrated in the capital area, including the heavy ion therapy center at Sinchon Severance Hospital of Yonsei University...

2026-08-26

Two production lines at radiopharmaceutical plant in Russia's Kaluga Region enter trial production

Rosatom recently announced that two production lines at its modern radiopharmaceutical manufacturing facility in the Kaluga Region have entered trial production. The facility, built in accordance with the Eurasian Economic Union's international Good Manufacturing Practice (GMP) standards, is equipped with high-level production equipment and is designed to supply safe, quality-controlled radiopharmaceuticals to the market. According to reports, Rosatom's subsidiary enterprises currently produce more than ten registered diagnostic and therapeutic radiopharmaceuticals, involving isotopes such as iodine-123, iodine-131, technetium-99m, and samarium-153. The new plant's production plan is based on the demand for radioisotope products from Russian medical institutions through 2030. The company...

2026-08-26

IAEA Study: Five-Star Rating System Can Improve CT Imaging Safety and Reduce Unnecessary Radiation Exposure

A new study led by the International Atomic Energy Agency (IAEA) in collaboration with Massachusetts General Hospital and Harvard Medical School in Boston, USA, shows that a five-star rating system can help hospitals optimize image quality, reduce radiation dose, and decrease unnecessary patient radiation exposure in computed tomography (CT) examinations. The study has been published in the European Journal of Radiology. CT imaging uses X-rays to obtain detailed images of internal body structures and is an important tool in diagnosing a wide range of diseases. The study notes that CT image quality is closely related to radiation dose—higher doses typically reduce image noise and improve clarity, but do not always yield additional diagnostic value. How to minimize radiation exposure while ensuring diagnostic accuracy is key to optimizing CT examination protocols.

2026-08-26

Molecular Partners Advances DLL3 Radiopharmaceutical MP0712 to Higher Dose Cohort

Swiss clinical-stage biotechnology company Molecular Partners AG recently announced its business progress and financial results for the first half of 2026. The company stated that its DLL3-targeting radioactive DARPin therapy MP0712 has advanced to the second therapeutic dose level in a U.S. multicenter Phase 1/2a clinical study, and patient enrollment for the new dose cohort is currently underway. MP0712 is a radiopharmaceutical targeting the tumor-associated antigen DLL3, carrying a therapeutic alpha-emitting radionuclide lead-212 (Pb-212) payload, co-developed by Molecular Partners and Orano Med, primarily for small cell lung cancer and other neuroendocrine tumors. According to the company's disclosure, the first dose cohort of MP0712...

2026-08-26

South Korea's SEC Joins National R&D Project for Active Dose Distribution Control Radiotherapy Equipment

South Korean electron beam source technology company SEC announced on August 25 that it has been selected as a joint research institution for the world's best active dose distribution control radiotherapy machine R&D project, and will participate in the development of core technologies related to next-generation radiotherapy equipment. The project is a newly established task under the Global Flagship Medical Device R&D Program of the South Korean government's medical device R&D fund, with a duration of 6 years and 6 months, starting from July this year and planned to continue until December 2032. The total project budget is 35.2 billion KRW, of which 28 billion KRW is government funding. Radexel serves as the lead institution, with SEC participating as a joint research institution. Other participating organizations include the Korea Atomic Energy Research Institute, Korea Testing Laboratory...

2026-08-25

South Korean team develops biodegradable microgel for localized radiation therapy

Pusan National University announced on August 25 that a research team led by Professor Yang Seung-yun from the Department of Biomaterials Science, in collaboration with Professor Kim Hoon-soo from the Department of Dermatology and Professor Kim Geun-young from the Department of Nuclear Medicine at Pusan National University Hospital, as well as SNBIA Co., Ltd., has developed a precision localized radiation therapy technology based on biodegradable radioactive isotope materials for the treatment of refractory keloids that tend to recur after surgery. Conceptual diagram of precision treatment technology for refractory keloids. Provided by Pusan National University. Keloids are caused by abnormal proliferation of fibroblasts and excessive accumulation of collagen after skin injury. Existing treatment methods include surgery, steroid injections, laser therapy, etc., but...

2026-08-25

Novartis Files Localized Production Application in China for Lutetium [177Lu] Vipivotide Tetraxetan

On August 24, information on the website of the Center for Drug Evaluation (CDE) of China's National Medical Products Administration showed that Novartis' nuclear medicine product Lutetium [177Lu] Vipivotide Tetraxetan had a localized production application submitted in China. On the same day, two indications for the drug were proposed for priority review, and the relevant review matters may correspond to this localized production application. Lutetium [177Lu] Vipivotide Tetraxetan, namely 177Lu-PSMA-617, is a radioligand therapy (RLT) drug acquired by Novartis following its acquisition of Endocyte. The drug consists of a small-molecule compound targeting prostate-specific membrane antigen (PSMA) conjugated to the therapeutic radionuclide Lutetium-177. Upon entering the bloodstream, the drug binds to prostate cancer cells expressing PSMA, and...

2026-08-25

Angolan Public Health and Medical Training Delegation Visits the Affiliated Hospital of Southwest Medical University, Focusing on Nuclear Medicine Diagnosis and Treatment Technologies

Recently, the "Angola Public Health and Medical Training Program," organized by the International Exchange Center of the Sichuan Provincial Health Commission, was held at the Affiliated Hospital of Southwest Medical University. An 18-member delegation comprising Angolan health administrators and medical personnel visited the hospital for exchange, with a focus on learning about the development and clinical application of nuclear medicine, urology, and other related disciplines. Jiang Yong, member of the Standing Committee of the Party Committee, Vice President of Southwest Medical University, and President of the Affiliated Hospital, welcomed the Angolan delegation and introduced the hospital's basic information. He stated that under the guidance of the Sichuan Provincial Health Commission, the hospital will leverage its disciplinary advantages as a university-affiliated hospital and a Sichuan Provincial Medical Center to carry out practical cooperation with Angola in talent cultivation, technical exchange, and hospital management.

2026-08-25

Russia and Algeria Advance Cooperation in Peaceful Uses of Nuclear Energy

August 22 news, Russian Ambassador to Algeria Alexey Solomatin said in an interview that Russia and Algeria are advancing cooperation in the field of peaceful uses of nuclear energy, with direct working contacts established between the relevant agencies of the two countries. Solomatin stated that cooperation between the two countries in this field is expanding. The basis for bilateral cooperation is the Intergovernmental Agreement on Cooperation in the Peaceful Uses of Nuclear Energy signed in 2014. In addition, Russia and Algeria signed the Roadmap for Cooperation in the Peaceful Uses of Nuclear Energy during the 2024 International Atomic Energy Expo (Atomexpo), outlining the main directions of bilateral cooperation. He noted that the practical implementation of the agreements will begin in 2...

2026-08-25

Russian Far Eastern Federal University Develops Ultrafast Ceramic Scintillators for Rapid Ionizing Radiation Detection

On August 21, 2026, scientists at the Russian Far Eastern Federal University, with support from the Russian Science Foundation, are developing ceramic materials for ultrafast detection of ionizing radiation. The results could be used in the future for medical diagnostics, baggage and cargo security screening, radiation monitoring, and scientific equipment requiring fast, precise radiation detection. The project, titled "Ultrafast Ceramic Scintillators for Ionizing Radiation Detection," is led by Anastasia Vonovskikh, a researcher at the Research and Education Center for Advanced Ceramic Materials, Department of Industrial Safety, Polytechnic Institute, Far Eastern Federal University. Scintillators are a class of materials that emit light when exposed to ionizing radiation. Detectors record these light signals to determine radiation intensity and energy. Currently, most related equipment uses single-crystal scintillators, but their production typically requires significant energy and resource inputs. The Far Eastern Federal University team proposes special ceramic materials as an alternative, aiming to improve detection speed and efficiency, making them more suitable for detecting trace amounts of radiation.

2026-08-25

Beijing Nuclear Industry Hospital and Aviation General Hospital Hold Nursing Academic Exchange Focusing on Nuclear Medicine Specialty Nursing and Continuous Home-Based Care

On August 21, Beijing Nuclear Industry Hospital, in collaboration with Aviation General Hospital, held a nursing academic exchange meeting. Nursing management teams, nursing backbone staff and related professionals from both hospitals attended the meeting, engaging in exchanges on humanistic nursing development, the "Internet+" continuous home-based care service model, and nuclear medicine specialty nursing, exploring practical pathways for high-quality development of nursing services. Jin Congjun, Vice President of Beijing Nuclear Industry Hospital, introduced the hospital's development overview in his speech and welcomed the visiting nursing expert team from Aviation General Hospital. He expressed his hope to leverage this exchange as an opportunity to establish a regular learning platform, promote mutual learning and complementarity between the two sides, and jointly enhance nursing service capabilities. Aviation General...

2026-08-25

Phase I of Jinjiang Ruisi Ke Particle Therapy Equipment Production Base Fully Operational

Recently, Phase I of the Ruisi Ke Advanced Particle Therapy Equipment Production Base for tumors, located in Dongshi Town, Jinjiang, Fujian, has been fully put into operation, marking new progress in the life and health industry sector of Quanzhou South Wing National High-Tech Zone. As the first launch project in the local effort to build the "China Nuclear Medicine Valley," this project is accelerating the clustering of the nuclear medical equipment industry chain. It is understood that all four production workshops of Phase I of the Ruisi Ke production base have commenced operations, with a total floor area of nearly 30,000 square meters. Inside the workshops, relevant personnel are performing precision machining on core components of the proton therapy system. The base possesses research and development, production, and testing capabilities for proton therapy systems and boron neutron capture therapy systems, making it one of the few...

2026-08-24